Stock CALTX CALLIDITAS THERAPEUTICS AB
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Calliditas Therapeutics AB

Equities

CALTX

SE0010441584

Market Closed - Nasdaq Stockholm
Other stock markets
 16:29:52 26/04/2024 BST 		5-day change 1st Jan Change
103.7 SEK -0.38% Intraday chart for Calliditas Therapeutics AB +3.18% -18.41%
04-25 European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading MT
04-24 Calliditas Therapeutics Says OLE Study Shows Treatment Response Consistent With Late-Stage NefIgArd Study's Findings MT

Evolution of the average Target Price on Calliditas Therapeutics AB

Price target over the last 5 years

History of analyst recommendation changes

23c622969.KNDBufxgKPQdKGZiJD-KaV7Nrn3HWGhCiElhHyX_6fU.H6mg-ooSRIx1bBcMagj6Pjm73T6eal0m_DFSRX_Mk51coJXNkFdSsXFLIw~f92073011a85ae507f4bcb6269f6a806

Analyst Recommendations on Calliditas Therapeutics AB

Guggenheim Adjusts Calliditas Therapeutics' Price Target to $18 From $21, Keeps Neutral Rating MT
HC Wainwright Initiates Coverage on Calliditas Therapeutics With Buy Rating, $60 Price Target MT
Guggenheim Initiates Calliditas Therapeutics at Neutral With $18 Price Target MT
HC Wainwright Adjusts Calliditas Therapeutics' Price Target to $62 From $52, Reiterates Buy Rating MT
Citigroup Adjusts Calliditas Therapeutics' Price Target to $84 From $51, Reiterates Buy Rating MT
ANALYST RECOMMENDATIONS : Alibaba, Goldman Sachs, Monday.com, Shaftesbury, 3M Company... Our Logo
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
103.7 SEK
Average target price
208 SEK
Spread / Average Target
+100.58%
High Price Target
270 SEK
Spread / Highest target
+160.37%
Low Price Target
161 SEK
Spread / Lowest Target
+55.26%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Calliditas Therapeutics AB

Guggenheim
HC Wainwright
Citigroup

Ratings for Calliditas Therapeutics AB

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. CALTX Stock
  4. Consensus Calliditas Therapeutics AB